HK1201042A1 - 用於治療干眼病的組合物 - Google Patents
用於治療干眼病的組合物Info
- Publication number
- HK1201042A1 HK1201042A1 HK15100994.9A HK15100994A HK1201042A1 HK 1201042 A1 HK1201042 A1 HK 1201042A1 HK 15100994 A HK15100994 A HK 15100994A HK 1201042 A1 HK1201042 A1 HK 1201042A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- treatment
- dry eye
- eye
- dry
- Prior art date
Links
- 208000003556 Dry Eye Syndromes Diseases 0.000 title 1
- 206010013774 Dry eye Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161544151P | 2011-10-06 | 2011-10-06 | |
PCT/US2012/058893 WO2013052760A1 (en) | 2011-10-06 | 2012-10-05 | Compositions for the treatment of dry eye |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1201042A1 true HK1201042A1 (zh) | 2015-08-21 |
Family
ID=47040830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15100994.9A HK1201042A1 (zh) | 2011-10-06 | 2015-01-29 | 用於治療干眼病的組合物 |
Country Status (17)
Country | Link |
---|---|
US (7) | US8957048B2 (zh) |
EP (1) | EP2765987A1 (zh) |
JP (1) | JP6209163B2 (zh) |
CN (2) | CN108175778A (zh) |
AU (1) | AU2012318556B2 (zh) |
BR (1) | BR112014008314B1 (zh) |
CA (1) | CA2851398C (zh) |
CL (1) | CL2014000863A1 (zh) |
HK (1) | HK1201042A1 (zh) |
IL (1) | IL231970A (zh) |
MX (1) | MX2014004203A (zh) |
MY (1) | MY169328A (zh) |
RU (1) | RU2651046C2 (zh) |
SG (1) | SG11201401323PA (zh) |
TW (1) | TWI642432B (zh) |
WO (1) | WO2013052760A1 (zh) |
ZA (1) | ZA201404121B (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
HUE049489T2 (hu) * | 2011-12-07 | 2020-09-28 | Allergan Inc | Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával |
US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
US20140377210A1 (en) * | 2013-06-21 | 2014-12-25 | Gnt, Llc | Artificial tear compositions |
US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
US10279005B2 (en) * | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
WO2016115050A1 (en) | 2015-01-12 | 2016-07-21 | Lagunita Llc | Micro-droplet delivery device and methods |
WO2016164830A1 (en) | 2015-04-10 | 2016-10-13 | Lagunita Llc | Piezoelectric dispenser with replaceable ampoule |
CN105311042B (zh) * | 2015-09-07 | 2019-04-12 | 广州国宇医药科技有限公司 | 一种糖醇组合物在制备治疗干眼症的药物中的应用 |
WO2017116826A1 (en) * | 2015-12-28 | 2017-07-06 | Indiana University Research And Technology Corporation | Identification of contact lens wearers predisposed to contact lens discomfort |
CN109689161A (zh) | 2016-08-19 | 2019-04-26 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物 |
GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
CA3039106A1 (en) | 2017-01-20 | 2018-07-26 | Kedalion Therapeutics, Inc. | Piezoelectric fluid dispenser |
JP7311160B2 (ja) * | 2017-08-18 | 2023-07-19 | アクリビスタ エルエルシー | ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 |
WO2019054491A1 (ja) * | 2017-09-14 | 2019-03-21 | 協同乳業株式会社 | 涙液分泌能・涙液安定性を改善するための飲食品または製剤 |
JP7436363B2 (ja) | 2017-12-08 | 2024-02-21 | ノバルティス アーゲー | 流体送達アライメントシステム |
US11679028B2 (en) | 2019-03-06 | 2023-06-20 | Novartis Ag | Multi-dose ocular fluid delivery system |
IL297215A (en) | 2020-04-17 | 2022-12-01 | Kedallon Therapeutics Inc | A hydrodynamically activated preservative free distribution system |
US11938057B2 (en) | 2020-04-17 | 2024-03-26 | Bausch + Lomb Ireland Limited | Hydrodynamically actuated preservative free dispensing system |
US11458220B2 (en) | 2020-11-12 | 2022-10-04 | Singletto Inc. | Microbial disinfection for personal protection equipment |
US11951123B2 (en) | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
CN114533582B (zh) * | 2022-02-25 | 2023-05-09 | 北京协和生物工程研究所有限公司 | 一种包含多种渗透压保护剂的眼周用组合物 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201706A (en) | 1978-09-22 | 1980-05-06 | Burton, Parsons & Company, Inc. | Treatment of corneal edema |
JPS56104814A (en) | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
WO1989001772A1 (en) | 1987-09-03 | 1989-03-09 | University Of Georgia Research Foundation, Inc. | Ocular cyclosporin composition |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
IT1224795B (it) | 1988-12-01 | 1990-10-24 | Sigma Tau Ind Farmaceuti | Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento |
ATE96022T1 (de) | 1989-08-03 | 1993-11-15 | Eisai Co Ltd | Verfahren zur photostabilisierung von augenspuelloesungen. |
US5681555A (en) | 1991-04-22 | 1997-10-28 | Gleich; Gerald J. | Method for the treatment of bronchial asthma by parenteral administration of anionic polymers |
DE4229494A1 (de) | 1992-09-04 | 1994-03-10 | Basotherm Gmbh | Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks |
US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
AU3484895A (en) | 1994-09-14 | 1996-03-29 | Taisho Pharmaceutical Co., Ltd. | Eye drops for repairing corneal disturbance |
US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
FI106923B (fi) | 1997-01-03 | 2001-05-15 | Cultor Ltd Finnsugar Bioproduc | Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa |
AR002194A1 (es) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
US5981607A (en) | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
IT1302307B1 (it) | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil |
US6585987B1 (en) | 1998-11-13 | 2003-07-01 | Continental Projects Limited | Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions |
DE19859910C2 (de) | 1998-12-23 | 2001-03-22 | Ratiopharm Gmbh | Orales Arzneimittel |
US6228392B1 (en) | 1999-04-29 | 2001-05-08 | Gene Tools, Llc | Osmotic delivery composition, solution, and method |
JP2004503593A (ja) | 2000-07-14 | 2004-02-05 | アラーガン、インコーポレイテッド | 増大した溶解度を持つ治療活性成分を含む組成物 |
CA2355814C (en) | 2000-09-14 | 2010-06-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition for ophthalmic use |
EP1339418B1 (en) | 2000-11-08 | 2009-09-23 | FXS Ventures, LLC | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US7045121B2 (en) | 2001-12-14 | 2006-05-16 | Allergan, Inc. | Ophthalmic compositions for lubricating eyes and methods for making and using same |
US7795203B2 (en) | 2002-09-30 | 2010-09-14 | Babizhayev Mark A | Method for topical treatment of eye disease and composition and device for said treatment |
WO2004084877A1 (ja) | 2003-03-26 | 2004-10-07 | Menicon Co., Ltd. | 眼科用組成物 |
US20050009836A1 (en) | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US7288520B2 (en) * | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) * | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7659270B2 (en) | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
WO2008027341A2 (en) | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
WO2008106228A2 (en) * | 2007-02-28 | 2008-09-04 | Aciex Therapeutics, Inc. | Methods and compositions for normalizing meibomian gland secretions |
JP4929245B2 (ja) | 2008-07-31 | 2012-05-09 | 株式会社ベッセル工業 | 工具類のグリップ |
EP2349232A1 (en) | 2008-10-20 | 2011-08-03 | Allergan, Inc. | Ophthalmic compositions useful for improving visual acuity |
AU2010256652B2 (en) * | 2009-06-05 | 2015-11-26 | Allergan, Inc. | Artificial tears and therapeutic uses |
DK2485779T3 (en) | 2009-10-07 | 2018-05-07 | Kerecis Ehf | A FRAME MATERIAL FOR SCREENING AND / OR OTHER TISSUE HEALING APPLICATIONS |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
HUE049489T2 (hu) * | 2011-12-07 | 2020-09-28 | Allergan Inc | Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával |
-
2012
- 2012-10-04 US US13/645,035 patent/US8957048B2/en active Active
- 2012-10-05 MX MX2014004203A patent/MX2014004203A/es active IP Right Grant
- 2012-10-05 EP EP12773477.0A patent/EP2765987A1/en active Pending
- 2012-10-05 CN CN201810156093.5A patent/CN108175778A/zh active Pending
- 2012-10-05 CN CN201280060322.4A patent/CN103974694A/zh active Pending
- 2012-10-05 US US14/349,978 patent/US20140242022A1/en not_active Abandoned
- 2012-10-05 MY MYPI2014001028A patent/MY169328A/en unknown
- 2012-10-05 CA CA2851398A patent/CA2851398C/en active Active
- 2012-10-05 TW TW101137051A patent/TWI642432B/zh active
- 2012-10-05 WO PCT/US2012/058893 patent/WO2013052760A1/en active Application Filing
- 2012-10-05 RU RU2014122945A patent/RU2651046C2/ru active
- 2012-10-05 BR BR112014008314-2A patent/BR112014008314B1/pt active IP Right Grant
- 2012-10-05 JP JP2014534753A patent/JP6209163B2/ja active Active
- 2012-10-05 AU AU2012318556A patent/AU2012318556B2/en active Active
- 2012-10-05 SG SG11201401323PA patent/SG11201401323PA/en unknown
-
2014
- 2014-04-06 IL IL231970A patent/IL231970A/en active IP Right Grant
- 2014-04-07 CL CL2014000863A patent/CL2014000863A1/es unknown
- 2014-06-05 ZA ZA2014/04121A patent/ZA201404121B/en unknown
-
2015
- 2015-01-21 US US14/601,781 patent/US10105386B2/en active Active
- 2015-01-29 HK HK15100994.9A patent/HK1201042A1/zh unknown
-
2018
- 2018-09-12 US US16/129,385 patent/US20190247419A1/en not_active Abandoned
-
2020
- 2020-02-06 US US16/784,081 patent/US20210000859A1/en not_active Abandoned
-
2021
- 2021-08-12 US US17/400,815 patent/US20220096523A1/en not_active Abandoned
-
2023
- 2023-08-28 US US18/456,839 patent/US20240122963A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1201042A1 (zh) | 用於治療干眼病的組合物 | |
GB2511713B (en) | Compositions for the treatment of bone fragility | |
ZA201403795B (en) | Formulations for the treatment of diabetes | |
EP2723384A4 (en) | TREATMENT OF PROTEINOPATHIES | |
HK1218724A1 (zh) | 用於治療瘻的組合物 | |
EP2773342A4 (en) | COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | |
IL227738B (en) | A new compound for the treatment of cystic fibrosis | |
EP2897613A4 (en) | TREATMENT COMPOSITIONS | |
EP2852403A4 (en) | METHOD FOR MODIFYING TISSUE | |
HK1215794A1 (zh) | 用於治療疾病的同種異體自噬體富集組合物 | |
PL2538918T3 (pl) | Cytocholina do leczenia jaskry | |
HRP20180011T1 (hr) | Spojevi za uporabu u liječenju filariaza | |
EP2841077A4 (en) | NUTRITIONAL FIBER COMPOSITIONS FOR THE TREATMENT OF METABOLISM DISORDERS | |
HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
LT2717690T (lt) | Oftalmologinės kompozicijos | |
LT2704747T (lt) | Akių lašai, skirti konjuktivochalazės gydymui | |
GB0911577D0 (en) | Compositions for the treatment of dry eye | |
HK1196953A1 (zh) | 用於治療糖尿病的製劑 | |
EP2696872A4 (en) | TREATMENT OF GLAUCOMA | |
GB201105302D0 (en) | Treatment of acidosis | |
GB201222546D0 (en) | Novel compounds and improved treatments for glaucoma | |
AU2011903969A0 (en) | Compositions for treating skin conditions |